Termination of targeted Therapy with BRAF-/MEK Inhibitors after an initial complete Response in Patients with metastatic Melanoma and its clinical Implications - a retrospective, multicenter ADOReg Study

M Haist, H Stege, P Mohr, F Meier, D Schadendorf, S Ugurel, E Livingstone, L Zimmer, R Herbst, C Pfohler, K Kahler, M Weichenthal, P Terheyden, D Nashan, Dirk Debus, M Kaatz, F Ziller, S Haferkamp, A Forschner, U Lei-ter-StoppkeA Kreuter, J Ulrich, J Kleemann, S Grabbe, C Loquai

Research output: Contribution to journalpublished Abstract (Journal)peer-review

Original languageEnglish
Pages (from-to)15-16
JournalJOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT
Volume19
Publication statusPublished - 2021

Cite this